Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of Serial Ketamine Infusions on Corticolimbic Functional Connectivity in Major Depression
Megha Vasavada, Joana Loureiro, Antoni Kubicki, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2020) Vol. 6, Iss. 7, pp. 735-744
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Functional connectomics in depression: insights into therapies
Ya Chai, Yvette I. Sheline, Desmond J. Oathes, et al.
Trends in Cognitive Sciences (2023) Vol. 27, Iss. 9, pp. 814-832
Open Access | Times Cited: 48
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)
Mauro Pettorruso, Roberto Guidotti, Giacomo d’Andrea, et al.
Psychiatry Research (2023) Vol. 327, pp. 115378-115378
Open Access | Times Cited: 23
Abnormal core functional connectivity on the pathology of MDD and antidepressant treatment: A systematic review
Jianxiu Li, Junhao Chen, Wenwen Kong, et al.
Journal of Affective Disorders (2021) Vol. 296, pp. 622-634
Closed Access | Times Cited: 55
The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits
Danica Nogo, Ashitija Jasrai, Haeun Kim, et al.
Psychopharmacology (2022) Vol. 239, Iss. 7, pp. 2011-2039
Closed Access | Times Cited: 32
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression
Joshua S. Siegel, Ben Julian A. Palanca, Beau M. Ances, et al.
Psychopharmacology (2021)
Open Access | Times Cited: 40
The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression
Muhammad Youshay Jawad, Joshua D. Di Vincenzo, Sebastian Badulescu, et al.
Neuropharmacology (2022) Vol. 223, pp. 109299-109299
Closed Access | Times Cited: 22
Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review
Aleksander Kwaśny, Julia Kwaśna, Alina Wilkowska, et al.
European Neuropsychopharmacology (2024) Vol. 86, pp. 20-34
Closed Access | Times Cited: 5
Triple-network model–based graph theory analysis of the effectiveness of low-dose ketamine in patients with treatment-resistant depression: two resting-state functional MRI clinical trials
Shu–Chen Wei, Li‐Kai Cheng, Tung‐Ping Su, et al.
The British Journal of Psychiatry (2025), pp. 1-9
Closed Access
Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review
Ilya Demchenko, Vanessa K. Tassone, Sidney H. Kennedy, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 21
Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies
Gustavo C. Medeiros, Malcolm Matheson, Isabella Demo, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 10, pp. 790-800
Closed Access | Times Cited: 11
Low-Dose Ketamine Improved Brain Network Integrity Among Patients With Treatment-Resistant Depression and Suicidal Ideation
Tung‐Ping Su, Li‐Kai Cheng, Pei-Chi Tu, et al.
Psychiatry Research (2025), pp. 116377-116377
Closed Access
Neuroimaging-Derived Biomarkers of the Antidepressant Effects of Ketamine
Artemis Zavaliangos‐Petropulu, Noor Al‐Sharif, Brandon Taraku, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2022) Vol. 8, Iss. 4, pp. 361-386
Open Access | Times Cited: 18
Ketamine-induced hippocampal functional connectivity alterations associated with clinical remission in major depression
Fan Zhang, Chengyu Wang, Xiaofeng Lan, et al.
Journal of Affective Disorders (2023) Vol. 325, pp. 534-541
Closed Access | Times Cited: 10
Review: The use of functional magnetic resonance imaging (fMRI) in clinical trials and experimental research studies for depression
Vasileia Kotoula, Jennifer W. Evans, Claire Punturieri, et al.
Frontiers in Neuroimaging (2023) Vol. 2
Open Access | Times Cited: 10
Neurocognitive effects of subanesthetic serial ketamine infusions in treatment resistant depression
Artemis Zavaliangos‐Petropulu, Shawn M. McClintock, Jacqueline Khalil, et al.
Journal of Affective Disorders (2023) Vol. 333, pp. 161-171
Open Access | Times Cited: 8
Functional MRI markers for treatment-resistant depression: Insights and challenges
Vasileia Kotoula, Jennifer W. Evans, Claire Punturieri, et al.
Progress in brain research (2023), pp. 117-148
Open Access | Times Cited: 8
Biomarkers of ketamine’s antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology
Alexandra Alario, Mark J. Niciu
Chronic Stress (2021) Vol. 5, pp. 247054702110142-247054702110142
Open Access | Times Cited: 18
Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?
Magdalena Więdłocha, Piotr Marcinowicz, Jan Komarnicki, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
The Use of Ketamine for the Treatment of Anhedonia in Depression
Liliana Patarroyo-Rodríguez, Stefanie Cavalcanti, Jennifer L. Vande Voort, et al.
CNS Drugs (2024) Vol. 38, Iss. 8, pp. 583-596
Closed Access | Times Cited: 2
Resting-state connectivity studies as a marker of the acute and delayed effects of subanaesthetic ketamine administration in healthy and depressed individuals: A systematic review
Vasileia Kotoula, Toby Webster, James Stone, et al.
Brain and Neuroscience Advances (2021) Vol. 5
Open Access | Times Cited: 17
Clinical MRI morphological analysis of functional seizures compared to seizure-naïve and psychiatric controls
Wesley T. Kerr, Hiroyuki Tatekawa, John K. Lee, et al.
Epilepsy & Behavior (2022) Vol. 134, pp. 108858-108858
Open Access | Times Cited: 12
Functional connectivity changes between amygdala and prefrontal cortex after ECT are associated with improvement in distinct depressive symptoms
Ann‐Kathrin Domke, Moritz Hempel, Corinna Hartling, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1489-1499
Open Access | Times Cited: 6
Treatment response with ketamine in chronic suicidality: An open label functional connectivity study
Adem Can, Daniel F. Hermens, Abdalla Z. Mohamed, et al.
Journal of Affective Disorders (2023) Vol. 331, pp. 92-100
Closed Access | Times Cited: 5
Anterior default mode network and posterior insular connectivity is predictive of depressive symptom reduction following serial ketamine infusion
Benjamin Wade, Joana Loureiro, Ashish Sahib, et al.
Psychological Medicine (2022) Vol. 52, Iss. 12, pp. 2376-2386
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top